Global Human Papillomavirus Vaccine Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Human Papillomavirus Vaccine Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Human Papillomavirus Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Bivalent
  • 1.2.3 Quadrivalent
  • 1.2.4 Nonavalent
• 1.3 Market by Application
  • 1.3.1 Global Human Papillomavirus Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Cervical Cancer
  • 1.3.3 Anal Cancer
  • 1.3.4 Penile Cancer
  • 1.3.5 Oropharyngeal Cancer
  • 1.3.6 Genital Warts
  • 1.3.7 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Human Papillomavirus Vaccine Sales Estimates and Forecasts 2017-2028
• 2.2 Global Human Papillomavirus Vaccine Revenue Estimates and Forecasts 2017-2028
• 2.3 Global Human Papillomavirus Vaccine Revenue by Region: 2017 VS 2021 VS 2028
• 2.4 Global Human Papillomavirus Vaccine Sales by Region
  • 2.4.1 Global Human Papillomavirus Vaccine Sales by Region (2017-2022)
  • 2.4.2 Global Sales Human Papillomavirus Vaccine by Region (2023-2028)
• 2.5 Global Human Papillomavirus Vaccine Revenue by Region
  • 2.5.1 Global Human Papillomavirus Vaccine Revenue by Region (2017-2022)
  • 2.5.2 Global Human Papillomavirus Vaccine Revenue by Region (2023-2028)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Human Papillomavirus Vaccine Sales by Manufacturers
  • 3.1.1 Global Top Human Papillomavirus Vaccine Manufacturers by Sales (2017-2022)
  • 3.1.2 Global Human Papillomavirus Vaccine Sales Market Share by Manufacturers (2017-2022)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Papillomavirus Vaccine in 2021
• 3.2 Global Human Papillomavirus Vaccine Revenue by Manufacturers
  • 3.2.1 Global Human Papillomavirus Vaccine Revenue by Manufacturers (2017-2022)
  • 3.2.2 Global Human Papillomavirus Vaccine Revenue Market Share by Manufacturers (2017-2022)
  • 3.2.3 Global Top 10 and Top 5 Companies by Human Papillomavirus Vaccine Revenue in 2021
• 3.3 Global Human Papillomavirus Vaccine Sales Price by Manufacturers (2017-2022)
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Human Papillomavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Human Papillomavirus Vaccine Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Human Papillomavirus Vaccine Sales by Type
  • 4.1.1 Global Human Papillomavirus Vaccine Historical Sales by Type (2017-2022)
  • 4.1.2 Global Human Papillomavirus Vaccine Forecasted Sales by Type (2023-2028)
  • 4.1.3 Global Human Papillomavirus Vaccine Sales Market Share by Type (2017-2028)
• 4.2 Global Human Papillomavirus Vaccine Revenue by Type
  • 4.2.1 Global Human Papillomavirus Vaccine Historical Revenue by Type (2017-2022)
  • 4.2.2 Global Human Papillomavirus Vaccine Forecasted Revenue by Type (2023-2028)
  • 4.2.3 Global Human Papillomavirus Vaccine Revenue Market Share by Type (2017-2028)
• 4.3 Global Human Papillomavirus Vaccine Price by Type
  • 4.3.1 Global Human Papillomavirus Vaccine Price by Type (2017-2022)
  • 4.3.2 Global Human Papillomavirus Vaccine Price Forecast by Type (2023-2028)

5 Market Size by Application

• 5.1 Global Human Papillomavirus Vaccine Sales by Application
  • 5.1.1 Global Human Papillomavirus Vaccine Historical Sales by Application (2017-2022)
  • 5.1.2 Global Human Papillomavirus Vaccine Forecasted Sales by Application (2023-2028)
  • 5.1.3 Global Human Papillomavirus Vaccine Sales Market Share by Application (2017-2028)
• 5.2 Global Human Papillomavirus Vaccine Revenue by Application
  • 5.2.1 Global Human Papillomavirus Vaccine Historical Revenue by Application (2017-2022)
  • 5.2.2 Global Human Papillomavirus Vaccine Forecasted Revenue by Application (2023-2028)
  • 5.2.3 Global Human Papillomavirus Vaccine Revenue Market Share by Application (2017-2028)
• 5.3 Global Human Papillomavirus Vaccine Price by Application
  • 5.3.1 Global Human Papillomavirus Vaccine Price by Application (2017-2022)
  • 5.3.2 Global Human Papillomavirus Vaccine Price Forecast by Application (2023-2028)

6 North America

• 6.1 North America Human Papillomavirus Vaccine Market Size by Type
  • 6.1.1 North America Human Papillomavirus Vaccine Sales by Type (2017-2028)
  • 6.1.2 North America Human Papillomavirus Vaccine Revenue by Type (2017-2028)
• 6.2 North America Human Papillomavirus Vaccine Market Size by Application
  • 6.2.1 North America Human Papillomavirus Vaccine Sales by Application (2017-2028)
  • 6.2.2 North America Human Papillomavirus Vaccine Revenue by Application (2017-2028)
• 6.3 North America Human Papillomavirus Vaccine Market Size by Country
  • 6.3.1 North America Human Papillomavirus Vaccine Sales by Country (2017-2028)
  • 6.3.2 North America Human Papillomavirus Vaccine Revenue by Country (2017-2028)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Human Papillomavirus Vaccine Market Size by Type
  • 7.1.1 Europe Human Papillomavirus Vaccine Sales by Type (2017-2028)
  • 7.1.2 Europe Human Papillomavirus Vaccine Revenue by Type (2017-2028)
• 7.2 Europe Human Papillomavirus Vaccine Market Size by Application
  • 7.2.1 Europe Human Papillomavirus Vaccine Sales by Application (2017-2028)
  • 7.2.2 Europe Human Papillomavirus Vaccine Revenue by Application (2017-2028)
• 7.3 Europe Human Papillomavirus Vaccine Market Size by Country
  • 7.3.1 Europe Human Papillomavirus Vaccine Sales by Country (2017-2028)
  • 7.3.2 Europe Human Papillomavirus Vaccine Revenue by Country (2017-2028)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Human Papillomavirus Vaccine Market Size by Type
  • 8.1.1 Asia Pacific Human Papillomavirus Vaccine Sales by Type (2017-2028)
  • 8.1.2 Asia Pacific Human Papillomavirus Vaccine Revenue by Type (2017-2028)
• 8.2 Asia Pacific Human Papillomavirus Vaccine Market Size by Application
  • 8.2.1 Asia Pacific Human Papillomavirus Vaccine Sales by Application (2017-2028)
  • 8.2.2 Asia Pacific Human Papillomavirus Vaccine Revenue by Application (2017-2028)
• 8.3 Asia Pacific Human Papillomavirus Vaccine Market Size by Region
  • 8.3.1 Asia Pacific Human Papillomavirus Vaccine Sales by Region (2017-2028)
  • 8.3.2 Asia Pacific Human Papillomavirus Vaccine Revenue by Region (2017-2028)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Human Papillomavirus Vaccine Market Size by Type
  • 9.1.1 Latin America Human Papillomavirus Vaccine Sales by Type (2017-2028)
  • 9.1.2 Latin America Human Papillomavirus Vaccine Revenue by Type (2017-2028)
• 9.2 Latin America Human Papillomavirus Vaccine Market Size by Application
  • 9.2.1 Latin America Human Papillomavirus Vaccine Sales by Application (2017-2028)
  • 9.2.2 Latin America Human Papillomavirus Vaccine Revenue by Application (2017-2028)
• 9.3 Latin America Human Papillomavirus Vaccine Market Size by Country
  • 9.3.1 Latin America Human Papillomavirus Vaccine Sales by Country (2017-2028)
  • 9.3.2 Latin America Human Papillomavirus Vaccine Revenue by Country (2017-2028)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Human Papillomavirus Vaccine Market Size by Type
  • 10.1.1 Middle East and Africa Human Papillomavirus Vaccine Sales by Type (2017-2028)
  • 10.1.2 Middle East and Africa Human Papillomavirus Vaccine Revenue by Type (2017-2028)
• 10.2 Middle East and Africa Human Papillomavirus Vaccine Market Size by Application
  • 10.2.1 Middle East and Africa Human Papillomavirus Vaccine Sales by Application (2017-2028)
  • 10.2.2 Middle East and Africa Human Papillomavirus Vaccine Revenue by Application (2017-2028)
• 10.3 Middle East and Africa Human Papillomavirus Vaccine Market Size by Country
  • 10.3.1 Middle East and Africa Human Papillomavirus Vaccine Sales by Country (2017-2028)
  • 10.3.2 Middle East and Africa Human Papillomavirus Vaccine Revenue by Country (2017-2028)
  • 10.3.3 Turkey
  • 10.3.4 Saudi Arabia

11 Company Profiles

• 11.1 Merck
  • 11.1.1 Merck Corporation Information
  • 11.1.2 Merck Overview
  • 11.1.3 Merck Human Papillomavirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.1.4 Merck Human Papillomavirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Merck Recent Developments
• 11.2 GlaxoSmithKline
  • 11.2.1 GlaxoSmithKline Corporation Information
  • 11.2.2 GlaxoSmithKline Overview
  • 11.2.3 GlaxoSmithKline Human Papillomavirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.2.4 GlaxoSmithKline Human Papillomavirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 GlaxoSmithKline Recent Developments
• 11.3 Sanofi
  • 11.3.1 Sanofi Corporation Information
  • 11.3.2 Sanofi Overview
  • 11.3.3 Sanofi Human Papillomavirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.3.4 Sanofi Human Papillomavirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Sanofi Recent Developments
• 11.4 Johnson & Johnson
  • 11.4.1 Johnson & Johnson Corporation Information
  • 11.4.2 Johnson & Johnson Overview
  • 11.4.3 Johnson & Johnson Human Papillomavirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.4.4 Johnson & Johnson Human Papillomavirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Johnson & Johnson Recent Developments
• 11.5 AstraZeneca
  • 11.5.1 AstraZeneca Corporation Information
  • 11.5.2 AstraZeneca Overview
  • 11.5.3 AstraZeneca Human Papillomavirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.5.4 AstraZeneca Human Papillomavirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 AstraZeneca Recent Developments
• 11.6 Serum Institute
  • 11.6.1 Serum Institute Corporation Information
  • 11.6.2 Serum Institute Overview
  • 11.6.3 Serum Institute Human Papillomavirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.6.4 Serum Institute Human Papillomavirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Serum Institute Recent Developments
• 11.7 Wantai Biological
  • 11.7.1 Wantai Biological Corporation Information
  • 11.7.2 Wantai Biological Overview
  • 11.7.3 Wantai Biological Human Papillomavirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.7.4 Wantai Biological Human Papillomavirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Wantai Biological Recent Developments
• 11.8 KM Biologics
  • 11.8.1 KM Biologics Corporation Information
  • 11.8.2 KM Biologics Overview
  • 11.8.3 KM Biologics Human Papillomavirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.8.4 KM Biologics Human Papillomavirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 KM Biologics Recent Developments
• 11.9 Bharat Biotech
  • 11.9.1 Bharat Biotech Corporation Information
  • 11.9.2 Bharat Biotech Overview
  • 11.9.3 Bharat Biotech Human Papillomavirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.9.4 Bharat Biotech Human Papillomavirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Bharat Biotech Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Human Papillomavirus Vaccine Industry Chain Analysis
• 12.2 Human Papillomavirus Vaccine Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Human Papillomavirus Vaccine Production Mode & Process
• 12.4 Human Papillomavirus Vaccine Sales and Marketing
  • 12.4.1 Human Papillomavirus Vaccine Sales Channels
  • 12.4.2 Human Papillomavirus Vaccine Distributors
• 12.5 Human Papillomavirus Vaccine Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Human Papillomavirus Vaccine Industry Trends
• 13.2 Human Papillomavirus Vaccine Market Drivers
• 13.3 Human Papillomavirus Vaccine Market Challenges
• 13.4 Human Papillomavirus Vaccine Market Restraints

14 Key Findings in The Global Human Papillomavirus Vaccine Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

• Table 1. Global Human Papillomavirus Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
• Table 2. Major Manufacturers of Bivalent
• Table 3. Major Manufacturers of Quadrivalent
• Table 4. Major Manufacturers of Nonavalent
• Table 5. Global Human Papillomavirus Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
• Table 6. Global Human Papillomavirus Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
• Table 7. Global Human Papillomavirus Vaccine Sales by Region (2017-2022) & (Kg)
• Table 8. Global Human Papillomavirus Vaccine Sales Market Share by Region (2017-2022)
• Table 9. Global Human Papillomavirus Vaccine Sales by Region (2023-2028) & (Kg)
• Table 10. Global Human Papillomavirus Vaccine Sales Market Share by Region (2023-2028)
• Table 11. Global Human Papillomavirus Vaccine Revenue by Region (2017-2022) & (US$ Million)
• Table 12. Global Human Papillomavirus Vaccine Revenue Market Share by Region (2017-2022)
• Table 13. Global Human Papillomavirus Vaccine Revenue by Region (2023-2028) & (US$ Million)
• Table 14. Global Human Papillomavirus Vaccine Revenue Market Share by Region (2023-2028)
• Table 15. Global Human Papillomavirus Vaccine Sales by Manufacturers (2017-2022) & (Kg)
• Table 16. Global Human Papillomavirus Vaccine Sales Share by Manufacturers (2017-2022)
• Table 17. Global Human Papillomavirus Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
• Table 18. Global Human Papillomavirus Vaccine Revenue Share by Manufacturers (2017-2022)
• Table 19. Human Papillomavirus Vaccine Price by Manufacturers (2017-2022) &(USD/Kg)
• Table 20. Global Human Papillomavirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 21. Global Human Papillomavirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Papillomavirus Vaccine as of 2021)
• Table 22. Human Papillomavirus Vaccine Manufacturing Base Distribution and Headquarters
• Table 23. Manufacturers Human Papillomavirus Vaccine Product Offered
• Table 24. Date of Manufacturers Enter into Human Papillomavirus Vaccine Market
• Table 25. Mergers & Acquisitions, Expansion Plans
• Table 26. Global Human Papillomavirus Vaccine Sales by Type (2017-2022) & (Kg)
• Table 27. Global Human Papillomavirus Vaccine Sales by Type (2023-2028) & (Kg)
• Table 28. Global Human Papillomavirus Vaccine Sales Share by Type (2017-2022)
• Table 29. Global Human Papillomavirus Vaccine Sales Share by Type (2023-2028)
• Table 30. Global Human Papillomavirus Vaccine Revenue by Type (2017-2022) & (US$ Million)
• Table 31. Global Human Papillomavirus Vaccine Revenue by Type (2023-2028) & (US$ Million)
• Table 32. Global Human Papillomavirus Vaccine Revenue Share by Type (2017-2022)
• Table 33. Global Human Papillomavirus Vaccine Revenue Share by Type (2023-2028)
• Table 34. Human Papillomavirus Vaccine Price by Type (2017-2022) & (USD/Kg)
• Table 35. Global Human Papillomavirus Vaccine Price Forecast by Type (2023-2028) & (USD/Kg)
• Table 36. Global Human Papillomavirus Vaccine Sales by Application (2017-2022) & (Kg)
• Table 37. Global Human Papillomavirus Vaccine Sales by Application (2023-2028) & (Kg)
• Table 38. Global Human Papillomavirus Vaccine Sales Share by Application (2017-2022)
• Table 39. Global Human Papillomavirus Vaccine Sales Share by Application (2023-2028)
• Table 40. Global Human Papillomavirus Vaccine Revenue by Application (2017-2022) & (US$ Million)
• Table 41. Global Human Papillomavirus Vaccine Revenue by Application (2023-2028) & (US$ Million)
• Table 42. Global Human Papillomavirus Vaccine Revenue Share by Application (2017-2022)
• Table 43. Global Human Papillomavirus Vaccine Revenue Share by Application (2023-2028)
• Table 44. Human Papillomavirus Vaccine Price by Application (2017-2022) & (USD/Kg)
• Table 45. Global Human Papillomavirus Vaccine Price Forecast by Application (2023-2028) & (USD/Kg)
• Table 46. North America Human Papillomavirus Vaccine Sales by Type (2017-2022) & (Kg)
• Table 47. North America Human Papillomavirus Vaccine Sales by Type (2023-2028) & (Kg)
• Table 48. North America Human Papillomavirus Vaccine Revenue by Type (2017-2022) & (US$ Million)
• Table 49. North America Human Papillomavirus Vaccine Revenue by Type (2023-2028) & (US$ Million)
• Table 50. North America Human Papillomavirus Vaccine Sales by Application (2017-2022) & (Kg)
• Table 51. North America Human Papillomavirus Vaccine Sales by Application (2023-2028) & (Kg)
• Table 52. North America Human Papillomavirus Vaccine Revenue by Application (2017-2022) & (US$ Million)
• Table 53. North America Human Papillomavirus Vaccine Revenue by Application (2023-2028) & (US$ Million)
• Table 54. North America Human Papillomavirus Vaccine Sales by Country (2017-2022) & (Kg)
• Table 55. North America Human Papillomavirus Vaccine Sales by Country (2023-2028) & (Kg)
• Table 56. North America Human Papillomavirus Vaccine Revenue by Country (2017-2022) & (US$ Million)
• Table 57. North America Human Papillomavirus Vaccine Revenue by Country (2023-2028) & (US$ Million)
• Table 58. Europe Human Papillomavirus Vaccine Sales by Type (2017-2022) & (Kg)
• Table 59. Europe Human Papillomavirus Vaccine Sales by Type (2023-2028) & (Kg)
• Table 60. Europe Human Papillomavirus Vaccine Revenue by Type (2017-2022) & (US$ Million)
• Table 61. Europe Human Papillomavirus Vaccine Revenue by Type (2023-2028) & (US$ Million)
• Table 62. Europe Human Papillomavirus Vaccine Sales by Application (2017-2022) & (Kg)
• Table 63. Europe Human Papillomavirus Vaccine Sales by Application (2023-2028) & (Kg)
• Table 64. Europe Human Papillomavirus Vaccine Revenue by Application (2017-2022) & (US$ Million)
• Table 65. Europe Human Papillomavirus Vaccine Revenue by Application (2023-2028) & (US$ Million)
• Table 66. Europe Human Papillomavirus Vaccine Sales by Country (2017-2022) & (Kg)
• Table 67. Europe Human Papillomavirus Vaccine Sales by Country (2023-2028) & (Kg)
• Table 68. Europe Human Papillomavirus Vaccine Revenue by Country (2017-2022) & (US$ Million)
• Table 69. Europe Human Papillomavirus Vaccine Revenue by Country (2023-2028) & (US$ Million)
• Table 70. Asia Pacific Human Papillomavirus Vaccine Sales by Type (2017-2022) & (Kg)
• Table 71. Asia Pacific Human Papillomavirus Vaccine Sales by Type (2023-2028) & (Kg)
• Table 72. Asia Pacific Human Papillomavirus Vaccine Revenue by Type (2017-2022) & (US$ Million)
• Table 73. Asia Pacific Human Papillomavirus Vaccine Revenue by Type (2023-2028) & (US$ Million)
• Table 74. Asia Pacific Human Papillomavirus Vaccine Sales by Application (2017-2022) & (Kg)
• Table 75. Asia Pacific Human Papillomavirus Vaccine Sales by Application (2023-2028) & (Kg)
• Table 76. Asia Pacific Human Papillomavirus Vaccine Revenue by Application (2017-2022) & (US$ Million)
• Table 77. Asia Pacific Human Papillomavirus Vaccine Revenue by Application (2023-2028) & (US$ Million)
• Table 78. Asia Pacific Human Papillomavirus Vaccine Sales by Region (2017-2022) & (Kg)
• Table 79. Asia Pacific Human Papillomavirus Vaccine Sales by Region (2023-2028) & (Kg)
• Table 80. Asia Pacific Human Papillomavirus Vaccine Revenue by Region (2017-2022) & (US$ Million)
• Table 81. Asia Pacific Human Papillomavirus Vaccine Revenue by Region (2023-2028) & (US$ Million)
• Table 82. Latin America Human Papillomavirus Vaccine Sales by Type (2017-2022) & (Kg)
• Table 83. Latin America Human Papillomavirus Vaccine Sales by Type (2023-2028) & (Kg)
• Table 84. Latin America Human Papillomavirus Vaccine Revenue by Type (2017-2022) & (US$ Million)
• Table 85. Latin America Human Papillomavirus Vaccine Revenue by Type (2023-2028) & (US$ Million)
• Table 86. Latin America Human Papillomavirus Vaccine Sales by Application (2017-2022) & (Kg)
• Table 87. Latin America Human Papillomavirus Vaccine Sales by Application (2023-2028) & (Kg)
• Table 88. Latin America Human Papillomavirus Vaccine Revenue by Application (2017-2022) & (US$ Million)
• Table 89. Latin America Human Papillomavirus Vaccine Revenue by Application (2023-2028) & (US$ Million)
• Table 90. Latin America Human Papillomavirus Vaccine Sales by Country (2017-2022) & (Kg)
• Table 91. Latin America Human Papillomavirus Vaccine Sales by Country (2023-2028) & (Kg)
• Table 92. Latin America Human Papillomavirus Vaccine Revenue by Country (2017-2022) & (US$ Million)
• Table 93. Latin America Human Papillomavirus Vaccine Revenue by Country (2023-2028) & (US$ Million)
• Table 94. Middle East and Africa Human Papillomavirus Vaccine Sales by Type (2017-2022) & (Kg)
• Table 95. Middle East and Africa Human Papillomavirus Vaccine Sales by Type (2023-2028) & (Kg)
• Table 96. Middle East and Africa Human Papillomavirus Vaccine Revenue by Type (2017-2022) & (US$ Million)
• Table 97. Middle East and Africa Human Papillomavirus Vaccine Revenue by Type (2023-2028) & (US$ Million)
• Table 98. Middle East and Africa Human Papillomavirus Vaccine Sales by Application (2017-2022) & (Kg)
• Table 99. Middle East and Africa Human Papillomavirus Vaccine Sales by Application (2023-2028) & (Kg)
• Table 100. Middle East and Africa Human Papillomavirus Vaccine Revenue by Application (2017-2022) & (US$ Million)
• Table 101. Middle East and Africa Human Papillomavirus Vaccine Revenue by Application (2023-2028) & (US$ Million)
• Table 102. Middle East and Africa Human Papillomavirus Vaccine Sales by Country (2017-2022) & (Kg)
• Table 103. Middle East and Africa Human Papillomavirus Vaccine Sales by Country (2023-2028) & (Kg)
• Table 104. Middle East and Africa Human Papillomavirus Vaccine Revenue by Country (2017-2022) & (US$ Million)
• Table 105. Middle East and Africa Human Papillomavirus Vaccine Revenue by Country (2023-2028) & (US$ Million)
• Table 106. Merck Corporation Information
• Table 107. Merck Description and Major Businesses
• Table 108. Merck Human Papillomavirus Vaccine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 109. Merck Human Papillomavirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 110. Merck Recent Developments
• Table 111. GlaxoSmithKline Corporation Information
• Table 112. GlaxoSmithKline Description and Major Businesses
• Table 113. GlaxoSmithKline Human Papillomavirus Vaccine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 114. GlaxoSmithKline Human Papillomavirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 115. GlaxoSmithKline Recent Developments
• Table 116. Sanofi Corporation Information
• Table 117. Sanofi Description and Major Businesses
• Table 118. Sanofi Human Papillomavirus Vaccine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 119. Sanofi Human Papillomavirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 120. Sanofi Recent Developments
• Table 121. Johnson & Johnson Corporation Information
• Table 122. Johnson & Johnson Description and Major Businesses
• Table 123. Johnson & Johnson Human Papillomavirus Vaccine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 124. Johnson & Johnson Human Papillomavirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 125. Johnson & Johnson Recent Developments
• Table 126. AstraZeneca Corporation Information
• Table 127. AstraZeneca Description and Major Businesses
• Table 128. AstraZeneca Human Papillomavirus Vaccine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 129. AstraZeneca Human Papillomavirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 130. AstraZeneca Recent Developments
• Table 131. Serum Institute Corporation Information
• Table 132. Serum Institute Description and Major Businesses
• Table 133. Serum Institute Human Papillomavirus Vaccine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 134. Serum Institute Human Papillomavirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 135. Serum Institute Recent Developments
• Table 136. Wantai Biological Corporation Information
• Table 137. Wantai Biological Description and Major Businesses
• Table 138. Wantai Biological Human Papillomavirus Vaccine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 139. Wantai Biological Human Papillomavirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 140. Wantai Biological Recent Developments
• Table 141. KM Biologics Corporation Information
• Table 142. KM Biologics Description and Major Businesses
• Table 143. KM Biologics Human Papillomavirus Vaccine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 144. KM Biologics Human Papillomavirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 145. KM Biologics Recent Developments
• Table 146. Bharat Biotech Corporation Information
• Table 147. Bharat Biotech Description and Major Businesses
• Table 148. Bharat Biotech Human Papillomavirus Vaccine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
• Table 149. Bharat Biotech Human Papillomavirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 150. Bharat Biotech Recent Developments
• Table 151. Key Raw Materials Lists
• Table 152. Raw Materials Key Suppliers Lists
• Table 153. Human Papillomavirus Vaccine Distributors List
• Table 154. Human Papillomavirus Vaccine Customers List
• Table 155. Human Papillomavirus Vaccine Market Trends
• Table 156. Human Papillomavirus Vaccine Market Drivers
• Table 157. Human Papillomavirus Vaccine Market Challenges
• Table 158. Human Papillomavirus Vaccine Market Restraints
• Table 159. Research Programs/Design for This Report
• Table 160. Key Data Information from Secondary Sources
• Table 161. Key Data Information from Primary Sources

List of Figures

• Figure 1. Human Papillomavirus Vaccine Product Picture
• Figure 3. Global Human Papillomavirus Vaccine Market Share by Type in 2021 & 2028
• Figure 3. Bivalent Product Picture
• Figure 4. Quadrivalent Product Picture
• Figure 5. Nonavalent Product Picture
• Figure 6. Global Human Papillomavirus Vaccine Market Share by Application in 2021 & 2028
• Figure 7. Cervical Cancer
• Figure 8. Anal Cancer
• Figure 9. Penile Cancer
• Figure 10. Oropharyngeal Cancer
• Figure 11. Genital Warts
• Figure 12. Others
• Figure 13. Human Papillomavirus Vaccine Report Years Considered
• Figure 14. Global Human Papillomavirus Vaccine Sales 2017-2028 (Kg)
• Figure 15. Global Human Papillomavirus Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
• Figure 16. Global Human Papillomavirus Vaccine Revenue 2017-2028 (US$ Million)
• Figure 17. Global Human Papillomavirus Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
• Figure 18. Global Human Papillomavirus Vaccine Sales Market Share by Region (2017-2022)
• Figure 19. Global Human Papillomavirus Vaccine Sales Market Share by Region (2023-2028)
• Figure 20. North America Human Papillomavirus Vaccine Sales YoY (2017-2028) & (Kg)
• Figure 21. North America Human Papillomavirus Vaccine Revenue YoY (2017-2028) & (US$ Million)
• Figure 22. Europe Human Papillomavirus Vaccine Sales YoY (2017-2028) & (Kg)
• Figure 23. Europe Human Papillomavirus Vaccine Revenue YoY (2017-2028) & (US$ Million)
• Figure 24. Asia-Pacific Human Papillomavirus Vaccine Sales YoY (2017-2028) & (Kg)
• Figure 25. Asia-Pacific Human Papillomavirus Vaccine Revenue YoY (2017-2028) & (US$ Million)
• Figure 26. Latin America Human Papillomavirus Vaccine Sales YoY (2017-2028) & (Kg)
• Figure 27. Latin America Human Papillomavirus Vaccine Revenue YoY (2017-2028) & (US$ Million)
• Figure 28. Middle East & Africa Human Papillomavirus Vaccine Sales YoY (2017-2028) & (Kg)
• Figure 29. Middle East & Africa Human Papillomavirus Vaccine Revenue YoY (2017-2028) & (US$ Million)
• Figure 30. The Human Papillomavirus Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
• Figure 31. The Top 5 and 10 Largest Manufacturers of Human Papillomavirus Vaccine in the World: Market Share by Human Papillomavirus Vaccine Revenue in 2021
• Figure 32. Global Human Papillomavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
• Figure 33. Global Human Papillomavirus Vaccine Sales Market Share by Type (2017-2028)
• Figure 34. Global Human Papillomavirus Vaccine Revenue Market Share by Type (2017-2028)
• Figure 35. Global Human Papillomavirus Vaccine Sales Market Share by Application (2017-2028)
• Figure 36. Global Human Papillomavirus Vaccine Revenue Market Share by Application (2017-2028)
• Figure 37. North America Human Papillomavirus Vaccine Sales Market Share by Type (2017-2028)
• Figure 38. North America Human Papillomavirus Vaccine Revenue Market Share by Type (2017-2028)
• Figure 39. North America Human Papillomavirus Vaccine Sales Market Share by Application (2017-2028)
• Figure 40. North America Human Papillomavirus Vaccine Revenue Market Share by Application (2017-2028)
• Figure 41. North America Human Papillomavirus Vaccine Sales Share by Country (2017-2028)
• Figure 42. North America Human Papillomavirus Vaccine Revenue Share by Country (2017-2028)
• Figure 43. U.S. Human Papillomavirus Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 44. Canada Human Papillomavirus Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 45. Europe Human Papillomavirus Vaccine Sales Market Share by Type (2017-2028)
• Figure 46. Europe Human Papillomavirus Vaccine Revenue Market Share by Type (2017-2028)
• Figure 47. Europe Human Papillomavirus Vaccine Sales Market Share by Application (2017-2028)
• Figure 48. Europe Human Papillomavirus Vaccine Revenue Market Share by Application (2017-2028)
• Figure 49. Europe Human Papillomavirus Vaccine Sales Share by Country (2017-2028)
• Figure 50. Europe Human Papillomavirus Vaccine Revenue Share by Country (2017-2028)
• Figure 51. Germany Human Papillomavirus Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 52. France Human Papillomavirus Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 53. U.K. Human Papillomavirus Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 54. Italy Human Papillomavirus Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 55. Russia Human Papillomavirus Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 56. Asia Pacific Human Papillomavirus Vaccine Sales Market Share by Type (2017-2028)
• Figure 57. Asia Pacific Human Papillomavirus Vaccine Revenue Market Share by Type (2017-2028)
• Figure 58. Asia Pacific Human Papillomavirus Vaccine Sales Market Share by Application (2017-2028)
• Figure 59. Asia Pacific Human Papillomavirus Vaccine Revenue Market Share by Application (2017-2028)
• Figure 60. Asia Pacific Human Papillomavirus Vaccine Sales Share by Region (2017-2028)
• Figure 61. Asia Pacific Human Papillomavirus Vaccine Revenue Share by Region (2017-2028)
• Figure 62. China Human Papillomavirus Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 63. Japan Human Papillomavirus Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 64. South Korea Human Papillomavirus Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 65. India Human Papillomavirus Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 66. Australia Human Papillomavirus Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 67. Taiwan Human Papillomavirus Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 68. Indonesia Human Papillomavirus Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 69. Thailand Human Papillomavirus Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 70. Malaysia Human Papillomavirus Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 71. Philippines Human Papillomavirus Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 72. Latin America Human Papillomavirus Vaccine Sales Market Share by Type (2017-2028)
• Figure 73. Latin America Human Papillomavirus Vaccine Revenue Market Share by Type (2017-2028)
• Figure 74. Latin America Human Papillomavirus Vaccine Sales Market Share by Application (2017-2028)
• Figure 75. Latin America Human Papillomavirus Vaccine Revenue Market Share by Application (2017-2028)
• Figure 76. Latin America Human Papillomavirus Vaccine Sales Share by Country (2017-2028)
• Figure 77. Latin America Human Papillomavirus Vaccine Revenue Share by Country (2017-2028)
• Figure 78. Mexico Human Papillomavirus Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 79. Brazil Human Papillomavirus Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 80. Argentina Human Papillomavirus Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 81. Middle East and Africa Human Papillomavirus Vaccine Sales Market Share by Type (2017-2028)
• Figure 82. Middle East and Africa Human Papillomavirus Vaccine Revenue Market Share by Type (2017-2028)
• Figure 83. Middle East and Africa Human Papillomavirus Vaccine Sales Market Share by Application (2017-2028)
• Figure 84. Middle East and Africa Human Papillomavirus Vaccine Revenue Market Share by Application (2017-2028)
• Figure 85. Middle East and Africa Human Papillomavirus Vaccine Sales Share by Country (2017-2028)
• Figure 86. Middle East and Africa Human Papillomavirus Vaccine Revenue Share by Country (2017-2028)
• Figure 87. Turkey Human Papillomavirus Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 88. Saudi Arabia Human Papillomavirus Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 89. U.A.E Human Papillomavirus Vaccine Revenue (2017-2028) & (US$ Million)
• Figure 90. Human Papillomavirus Vaccine Value Chain
• Figure 91. Human Papillomavirus Vaccine Production Process
• Figure 92. Channels of Distribution
• Figure 93. Distributors Profiles
• Figure 94. Bottom-up and Top-down Approaches for This Report
• Figure 95. Data Triangulation
• Figure 96. Key Executives Interviewed